^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine)

    i
    Associations
    News

    Trials

    Company:
    UniQuest
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts (TheraVACCS) (NCT02750202)
    Phase 3
    University of Pretoria
    Active, not recruiting
    Last update posted :
    05/08/2024
    Initiation :
    07/01/2018
    Primary completion :
    05/31/2025
    Completion :
    07/31/2025
    CD4
    |
    Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine)
    Vaccine Therapy in Preventing HPV in HIV-Positive Women in India (NCT00667563)
    Phase 1
    AIDS Malignancy Consortium
    Completed
    Last update posted :
    03/19/2024
    Initiation :
    08/01/2009
    Primary completion :
    11/01/2012
    Completion :
    11/01/2012
    CD4
    |
    Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine)
    Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer (NCT04096911)
    Phase 2
    Buhai Wang
    Unknown status
    Last update posted :
    09/20/2019
    Initiation :
    07/31/2019
    Primary completion :
    03/31/2021
    Completion :
    03/31/2021
    PD-L1
    |
    cisplatin • Tyvyt (sintilimab) • Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine)